We have a strong focus on research and evidence-based patient care. Our faculty are engaged in multiple research endeavors. This includes translational research for regenerative medicine treatments of fecal incontinence, clinical research for integration of palliative care into surgical treatment pathways and quality care improvement research to improve clinical outcomes in colon and rectal surgery. Partial colectomy vs. Nicole Wieghard , Sub I: Dr. Jaime Bohl ClinicalTrials.
Aim 1. Compare PROs e. Aim 2. Compare clinical outcomes e. Aim 3: Compare healthcare utilization between patients with QoL-limiting diverticular disease randomized to elective colectomy vs.
Jaime Bohl This is a two-center, first-in-human prospective study of the immediate and long-term safety of the BioSphincter, an implanted internal anal sphincter IAS bioengineered from autologous cells to treat patients with severe passive FI who have failed standard therapies. Fecal Incontinence FI is the inability to control your bowel movements, causing stool feces to leak unexpectedly from the rectum.
It is a problem faced by about 1 in 12 adults in the US. For some patients, medical treatments have not allowed for sustained resolution of FI. Cellf BIO provides a treatment that aims to restore the normal physiological function of the anorectum.
View Faculty Expertise Profile. Residents learn endoscopy, as well as clinical and surgical management of anorectal, colon and rectal diseases. Residents participate in open, laparoscopic and robotic procedures.
